| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/21/2004 | EP1409527A1 Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 04/21/2004 | EP1409526A2 An inducer of apoptosis |
| 04/21/2004 | EP1409525A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 04/21/2004 | EP1409524A2 Target for antiviral therapy |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409522A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/21/2004 | EP1409521A2 Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| 04/21/2004 | EP1409520A2 Vegfr-3 inhibitor materials and methods |
| 04/21/2004 | EP1409517A2 Fusion proteins based upon somatostatin receptors |
| 04/21/2004 | EP1409516A2 Aromatic sulfenates for type i phototherapy |
| 04/21/2004 | EP1409515A1 Process for extracting collagen from marine invertebrates |
| 04/21/2004 | EP1409510A2 Biological pacemaker |
| 04/21/2004 | EP1409508A2 Mammalian neuralized family transcriptional regulators and uses therefor |
| 04/21/2004 | EP1409507A2 Compositions, methods and kits relating to remodelin |
| 04/21/2004 | EP1409504A2 Secretory molecules |
| 04/21/2004 | EP1409482A2 Dye-sulfenates for dual phototherapy |
| 04/21/2004 | EP1409025A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 04/21/2004 | EP1409015A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 04/21/2004 | EP1409012A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 04/21/2004 | EP1409011A1 Prime-boost vaccination strategy |
| 04/21/2004 | EP1409008A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 04/21/2004 | EP1409006A2 Methods of treating diabetes mellitus |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1409004A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 04/21/2004 | EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408811A2 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
| 04/21/2004 | EP1408770A2 Gelling vegetable protein |
| 04/21/2004 | EP1408759A2 Human secreted proteins |
| 04/21/2004 | EP1408753A2 Compounds effecting neuron remodeling and assays for same |
| 04/21/2004 | EP1408736A2 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same |
| 04/21/2004 | EP1287355B1 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 04/21/2004 | EP1257577B1 Process for solubilizing glucagon-like peptide 1 (glp-1) compounds |
| 04/21/2004 | EP1242603B1 Vectors and method for producing recombinant proteins in fungi |
| 04/21/2004 | EP1232396B1 Assay of isomerised and/or optically inverted proteins |
| 04/21/2004 | EP1141019B1 Substance for producing highly effective anti-tumour medicaments and corresponding method |
| 04/21/2004 | EP1071701A4 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 04/21/2004 | EP1007065B1 Preparation of collagen |
| 04/21/2004 | EP0989858B1 Cd28/ctla-4 inhibiting peptidomimetics and pharmaceutical compositions thereof |
| 04/21/2004 | EP0859847B1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/21/2004 | EP0856007B1 Cyclopeptide derivatives |
| 04/21/2004 | EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/21/2004 | EP0714406B1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 04/21/2004 | EP0641215B1 Protease-resistant thrombomodulin analogs |
| 04/21/2004 | CN1491281A Neurotonin and use thereof |
| 04/21/2004 | CN1491280A Synovial membrane cell protein |
| 04/21/2004 | CN1491233A Long lasting growth hormone releasing factor derivatives |
| 04/21/2004 | CN1491232A Modified leptin with reduced immunogenicity |
| 04/21/2004 | CN1491231A Modified keratinocyte growth factor (KGF) with reduced immunogenicity |
| 04/21/2004 | CN1491116A Hepatitis B virus treatment |
| 04/21/2004 | CN1490333A Insulinotropic peptide and its use |
| 04/21/2004 | CN1490332A Recombinant human IA-2 antigen preparing method |
| 04/21/2004 | CN1490331A Sodium/hydrion inverse runner coding gene and application thereof |
| 04/21/2004 | CN1490325A Human gene RHBDL2 related to nervous system development |
| 04/21/2004 | CN1490324A Human gene NETRIN-G2 related to nervous system development |
| 04/21/2004 | CN1490056A Immune method and composition for HIV-1 |
| 04/21/2004 | CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease |
| 04/21/2004 | CN1146666C Positive-negative selection for homologous recombination |
| 04/21/2004 | CN1146664C Fusion polypeptides comprising and IgE-binding domain and HSA component, and their diagnostic and therapeutic uses |
| 04/21/2004 | CN1146576C Proteins from mammaliam liver and their use in oncology |
| 04/21/2004 | CN1146442C Lympha toxin-alpha/beta compositions as anti tumor agent and antilympha toxin beta receptor antibody |
| 04/21/2004 | CN1146441C Composition of containing lympha toxin beta receptor |
| 04/21/2004 | CN1146440C Vascular endothelial growth factor-B |
| 04/21/2004 | CN1146322C Pesticidal agent |
| 04/20/2004 | US6723893 Mice having a mutant SOD-1-encoding transgene |
| 04/20/2004 | US6723841 Corticotropin-releasing factor2 receptors |
| 04/20/2004 | US6723840 Nucleic acid sequence encoding a thermomyces lanuginosus-gamma , (tl- gamma ) protein comprising a specific amino acid sequence |
| 04/20/2004 | US6723839 Partial gene sequence from pelargonium to control ethylene levels in geraniums |
| 04/20/2004 | US6723838 Signal transducing synaptic molecules and uses thereof |
| 04/20/2004 | US6723837 Nucleic acid molecule and encoded protein associated with sterol synthesis and metabolism |
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723831 Removal antibodies from body fluids |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723707 Flanked by sv40 intron and polyadenylation signal sequences; genetic engineering |
| 04/20/2004 | US6723705 Gene expression; activating t-cells ability to bind cd28 or ctla4 ligands; antimetastasis and anticarcinogenic agents |
| 04/20/2004 | US6723701 Having different amino acid sequence or chemically modified so the isoelectric point is lower to improve bioavailability relative the unmodified cationic polypeptide; dna; expression vectors; transformed cells; treating neuropathies |
| 04/20/2004 | US6723700 Polypeptide increase blood/brain barrier permeability |
| 04/20/2004 | US6723699 Administering as cholinergic agent to treat nervous system disorders |
| 04/20/2004 | US6723698 Methods and compositions for the treatment of motor neuron injury and neuropathy |
| 04/20/2004 | US6723697 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 04/20/2004 | US6723696 Drug screening for agents to treat hypercalcemia and osteoporosis |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723561 Polypeptides |
| 04/20/2004 | US6723560 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/20/2004 | US6723559 Nucleotide sequences coding polypeptide for use in the prevention of viral diseases |
| 04/20/2004 | US6723558 Comprise mixtures of 10,000 different recombinant viruses that each express a different hiv env variant containing both constant and variable regions; used as vaccines; envelop proteins (env) |
| 04/20/2004 | US6723557 Provides a tool to identify the genes and factors involved in the polycystic kidney disease pathway, for drug screening and treatment; location of vulva (lov-1) gene |
| 04/20/2004 | US6723556 Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723551 Gene expression control; genetic engineering |
| 04/20/2004 | US6723538 Therapy for infections, immunology diseases |
| 04/20/2004 | US6723535 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 04/20/2004 | US6723534 Polypeptide for use in the treatment of fertility defects in humans |
| 04/20/2004 | US6723532 Plasmid for use in gene therapy |
| 04/20/2004 | US6723531 Method for modulating expression of exogenous genes in mammalian systems, and products related thereto |
| 04/20/2004 | US6723530 Polynucleotides encoding proexendin, and methods and uses thereof |
| 04/20/2004 | US6723522 For use as an antibody, in expression systems, for measuring activity of the cotransporter, in drug screening and design, or as a reagent for making a probe or a pcr primer, making transgenic animal |
| 04/20/2004 | US6723521 Method for screening compounds which modulate glucose transporting activity |
| 04/20/2004 | US6723520 Antibodies that bind chemokine teck |